Program


Sunday, June 13, 2010

3:00 p.m. - 7:30 p.m.

Registration

4:45 p.m. - 6:15 p.m.

Reception

6:30 p.m. - 6:45 p.m.

Conference Welcome & Opening Remarks

6:45 p.m. - 10:00 p.m.

Session 1:  Exposure to Medical Personnel, Patients, and the Public:  Trends & Issues
Organizers:  Mary Schubauer-Berigan, National Institute for Occupational Safety & Health, Cincinnati, OH, USA; Alice Sigurdson, National Cancer Institute, Bethesda, MD, USA

  1. Challenges in occupational dosimetry for interventional fluoroscopy
    Donald Miller, Uniformed Services University, National Navy Medical Center, Bethesda, MD, USA.
  2. Personnel dose estimation for interventional cardiology and other higher dose procedures

  3. Steve Simon, National Cancer Institute, Bethesda, MD, USA.
  4. Exposures of medical workers and the dose registry of Canada

  5. Dan Krewski, University of Ottawa, Ottawa, Ontario, Canada.
  6. Medical imaging and doses to the public

  7. Rebecca Smith-Bindman, UCSF and National Cancer Institute, Bethesda, MD, USA.
  8. Medical Exposures of the U.S. Population: New Developments since NCRP Report No. 160
    David Schauer, National Council on Radiation Protection and Measurements, Bethesda, MD, USA.
  9. Discussion

  10. Mary Schubauer-Berigan, National Institute for Occupational Safety & Health, Cincinnati, OH, USA.

Monday, June 14, 2010

7:30 a.m.- 1:00 p.m.

Registration

6:00 p.m. - 7:30 p.m.

 

8:00 a.m. - 9:00 a.m.

Breakfast

9:00 a.m. - 12:15 p.m.

Session 2:  Cancer and Non-Cancer Late Effects of Therapeutic Radiation
Organizers: Sarah Darby, Oxford University, UK; John Zimbrick, Colorado State University, Ft. Collins, CO, USA

  1. Predicting risk of second cancers following radiotherapy

  2. Igor Shuryak, Columbia University, New York, NY USA
  3. Radiation-associated lung cancer after radiotherapy

  4. Candace Correa, University of Michigan Medical Center, Ann Arbor, MI, USA
  5. Dose-response relationships for radiation-induced heart disease
    Sarah Darby, Oxford University, UK
  6. Radiation-related second cancers and cardiovascular outcomes in the Childhood Cancer Survivors Study

  7. Peter Inskip, National Cancer Institute, Bethesda, MD, USA
  8. Statistical adventures in navigating the dose-volume-outcome landscape in radiotherapy

  9. Joseph Deasy, Department of Radiation Oncology, Washington University School of Medicine, St. Louis, MO, USA
  10. Discussion

  11. Martin Colman, University of Texas Medical Branch-Galveston, TX, USA

12:15 p.m. - 1:15 p.m.

Lunch

7:00 p.m. - 9:45 p.m.

Session 3:  Genetic Susceptibility to Radiation
Organizers:  Dan Stram, University of Southern California, Los Angeles, CA, USA; Parveen Bhatti, Fred Hutchinson Cancer Research Center, Seattle, WA, USA

  1. The Life and Times of Genome-Wide Scans

  2. Chris Haiman, University of Southern California, Los Angeles, CA USA.
  3. Statistical methods in genome-wide association studies related to the search for gene and radiation interactions

  4. Daniel Stram, University of Southern California, Los Angeles, CA, USA
  5. The WECARE study of gene-radiation exposure interactions as a cause of contralateral breast cancer

  6. Jonine Bernstein, Memorial Sloan-Kettering Cancer Center, New York, NY, USA
  7. SNPs from GWA Studies:  What are Their Implications for Understanding Individual Differences in Susceptibility to Late Effects of Radiation Exposure?

  8. Parveen Bhatti, Fred Hutchinson Cancer Research Center, Seattle, WA, USA
  9. Discussion

  10. Harry Cullings, Radiation Effects Research Foundation, Japan

Tuesday, June 15, 2010

7:30 a.m. - 3:15 p.m.

Registration

5:00 p.m. - 6:30 p.m.

 

8:00 a.m. - 9:00 a.m.

Breakfast

9:00 a.m. - 12:15 p.m.

Session 4:  New Technologies in Radiation Medicine
Organizers:  Amy Kronenberg, Lawrence Berkeley National Laboratory, CA, USA; Martin Colman, University of Texas Medical Branch-Galveston, TX, USA

  1. Radiotherapy Technology: Form Follows Function

  2. T. Rockwell (Rock) Mackie, University of Wisconsin, Madison, WI, USA
  3. Electronic Brachytherapy: The Technology and Implications for Patient Treatment

  4. Tom Rusch, XOft Corporation, Sunnyvale, CA, USA
  5. Epidemiology of CT scan exposure

  6. Amy Berrington de Gonzalez, National Cancer Institute, Bethesda, MD, USA
  7. The Advantages ofProton Therapy over Conventional Radiation Therapy for Pediatric Cancers

  8. Robert (Rusty) Marcus, Dept of Radiation Oncology, Univ. of Florida & Univ. of Florida Proton Therapy Inst, Florida USA
  9. Impacts on endothelial cell adhesion following exposures to charged particle radiation and the relation to vascular risks

  10. Dennis Kucik, University of Alabama, Birmingham, AL, USA
  11. Discussion

  12. Martin Colman, University of Texas Medical Branch, Galveston, TX, USA
    Amy Kronenberg, Lawrence Berkeley National Laboratory, CA, USA

12:15 p.m. - 1:15 p.m.

Lunch

12:15 p.m. - 1:15 p.m.

2012 Organizer's Meeting

1:15 p.m. - 3:15 p.m.

Poster Session

6:00 p.m. - 9:00 p.m.

Conference Banquet
     Best New Poster Announcement
     New Investigator Recognition
     Banquet Speaker - Dale Preston, HiroSoft International, Eureka, CA, USA
          The Long and Winding Road to Radiation Risk and Protection

9:00 p.m. - 10:00 p.m.

Square Dance

Wednesday, June 16, 2010

7:30 a.m. - 9:00 a.m.

Registration

8:00 a.m. - 9:00 a.m.

Breakfast

9:00 a.m. - 11:45 a.m.

Session 5:  Lose Dose Radiation Effects
Organizers:  Sally Amundson, Columbia University; Peter Jacob, Helmholtz Zentrum München, Germany

  1. Studies of Signaling Pathways in Bystander Cells and the Impact of Sub-Cellular Localization of Sources of Oxidative Stress

  2. Kathy Held, Massachusetts General Hospital, Boston, MA, USA.
  3. Significance of Epigenetic Effects in the Low Dose Range

  4. Autumn Bernal, Duke University, Raleigh, NC, USA.
  5. Low Dose Radiation Metabolomics

  6. Albert Fornace, Georgetown University Medical Center, Washington DC, USA
  7. Low Radiation Dose Epidemiological Studies

  8. Peter Jacob, Helmholtz Zentrum München, Germany.
  9. Discussion

  10. Jerome Puskin, Environmental Protection Agency, USA

11:45 a.m. - 12:00 p.m.

Conference Conclusion

12:00 p.m.

Conference Adjournment
Lunch on your own